{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Commitment to MCM Development Reflected in New Draft Guidance on Medical Countermeasure Priority Review Vouchers",
    "url": "https://www.lexblog.com/2018/01/29/7442/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-5ZHB4MD1",
        "url": "https://www.lexblog.com/lib/5ZHB4MD1/"
    },
    "datePublished": "2018-01-29T11:08:55-05:00",
    "dateModified": "2021-07-08T14:32:44-04:00",
    "author": {
        "@type": "Person",
        "name": "Denise Esposito, Amy Leiser"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Covington & Burling LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Inside Government Contracts",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.insidegovernmentcontracts.com/?p=7442",
    "sourceStability": "may-move"
}